A 72-year-old man with GOLD stage III COPD on LAMA monotherapy has had two moderate exacerbations in the past year requiring oral steroids and one hospitalization. He continues to have dyspnea on exertion. According to GOLD recommendations, which change in inhaled therapy is most appropriate?